Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Obstetrics and Gynecology.
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Obstetrics and Gynecology.
April 28, 2021
Early Bird Registration
April 20, 2021
October 25-27, 2021
The Global Conference on Gynecology and Obstetrics will continue to provide two days of in-depth exploration of research and development pertaining to Obstetrics and Gynecology and will include a wide range of topics combining plenary sessions and skill-building workshops while providing multiple opportunities for networking. It will be held from October 25-27, 2021 Vancouver, Canada. The theme of the conference is “Notable Studies on Safety Methods in Obstetrics and Gynecology”.
The conference will bring young and celebrated researchers, academicians, students, business professionals and Gynecologists from around the world to discuss current trends and increase their knowledge in the field and learn about exciting new developments. The scientific program is tailored to impart this information to provide the most recent developments for all modalities of Gynecology. Many important topics such as Pediatric Gynecology, Abortion and Complications, Pregnancy Hypertension, Gynecological Oncology and Women Health and Nursing will be covered.
Conferences like this may facilitate to speed up the development of effective interventions, new strategies and therapies for gynecologists and obstetricians to use. It provides a common platform for renowned scientists and advance practice obstetricians from all over the world to discuss various developments in the field of Gynecology and Obstetrics. We hope this conference will witness invaluable scientific discussions and parallel sections that will contribute to future advancements in Gynecology and Obstetrics.
We invite you to attend an exciting scientific program comprising plenary and keynote talks, several invited talks, oral presentations multiple poster sessions, and networking events.
We are looking forward to see you at Gynecology-2021 in Vancouver, Canada.
SurgeonUniversity of ZuliaVenezula
He was a doctor with more than 10 years of experience in Perinatology, Ultrasound Level IV (ISUOG-FMF). Control and monitoring of High Risk Pregnancy-Critical Obstetric Care. Normal / High risk delivery care. Specialized External Consultations. Assisted Reproduction: Controlled stimulation of the ovary, Artificial insemination, IVF, Ovarian Puncture for Oocyte extraction. Gynecological, Oncological and Reproductive Surgery of High, Medium and Low Complexity, Minimally Invasive. Laparoscopy. Diagnostic and Therapeutic Hysteroscopy. Gynecological Laser. Education & Experience details ONCO-GYNECOLOGICAL AND ADVANCED REPRODUCTIVE SURGERY. University of Valencia. Valencian Institute of Fertility (IVI). La Fe Hospital. Manises Hospital. Valencia. Spain. ASSISTED REPRODUCTION AND INFERTILITY. Francisco de Vittoria University. Valencia. Spain. GYNECOLOGICAL AND REPRODUCTIVE ENDOCRINOLOGY. University of Alcalá. Madrid. Spain MASTER AND POST GRADUATE IN AESTHETIC CLINICAL MEDICINE. IAEMCE. Buenos Aires. Argentina. EXPERT DOCTOR IN LASER IN GYNECOLOGY. AILMED. Ibero-American Academy of Medical Laser ONCOLOGICAL GYNECOLOGY. Hospital Clinic University of Barcelona. Barcelona. Spain FETAL AND PERINATAL MEDICINAL. REPRODUCTIVE ULTRASOUND. Fetal Medicine Foundation. UK. Fetal Medicine Barcelona. Spain. Member of Societies and Academies: International Society of Ultrasound in Obstetrics and Gynecology. (ISOUG). European Society of Human Reproduction and Embriology (ESHRE) American Society of Breats Wish. (ASBD). Online and Presential Academy of Aesthetic and Regenerative Medicine, Surgery and Gynecology. (AMGER) Argentine Association of Aesthetic Medicine. (AAME). Argentine Federation of Gynecology and Obstetrics Societies. (FASGO). Latin American Federation of Obstetrics and Gynecology Societies (FLASGO). Brazilian Federation of Hospital Administrators (FBAH). Illustrious College of Guipúzcoa. Saint Sebastian. Basque Country. Spain Illustrious Official College of Physicians of Madrid. Spain Argentine Society of Controversies in Gynecology and Obstetrics. (SACGO). Ibero-American Academy of Medical Laser. (AILAMED) Colombian Medical College. Bogotana Association of Gynecology and Obstetrics. (ASBOG) Venezuelan Association of Ultrasound in Medicine (AVUM).
Head of DepartmentAIIMSIndia
Professor.Dr. Surekha Kishore is now professor and head at the AIIMS and 29 years of experience in teaching, training and research related to Medical( Undergraduates and postgraduates), paramedical students and non Teaching staff as well as field functionaries related to Health. Worked as teaching faculty for 10years at Mahatma Gandhi Institute of Medical Sciences. Sewagram, Wardha ( MGIMS) Maharastra and 20 years in Uttrakhand.(10 years approx. in Himalayan Institute of Medical Sciences and 2 years at Sri Guru Ram Rai Institute of Medical & Health Sciences) and since last 8 years in AIIMS, Rishikesh. Worked as Dean Academics at AIIMS,Rishikesh till Aug 2019.Presently working as Professor and Head, department of Community and Family Medicine &Dean Social Outreach at AIIMS Rishikesh. Research work includes more than 80 projects.( international and national). All my work had been mainly community based especially related to Reproductive & Child Health including MCH (maternal & child) and adolescent health along with Community Partnership. Master trainer for adolescent Health and Reproductive & Child Health. National Trainer for Field NGOs and ASHA under NRHM. Has presented and published around 91 papers in national and international conferences and journals. Members of various associations related to Public Health and Reviewer of National and International Journals. Member of Advisory Board of Association IAPSM-UP/UK Member Editorial board-IJCH & Indian Journal of Community & Family Medicine. Master trainer for adolescent Health and Reproductive & Child Health. National Trainer for Field NGOs and ASHA under NRHM. Course Coordinator for IGNOU Bridge Course at AIIMS Rishikesh.Course Coordinator for IAPC. Organized & participated as resource person in various training programmes and training workshops.Organised National Conference,Training programmes, and workshops at National, State & District level. Delivered Guest lectures in various International and National conferences ,CMEs and acted as resource person for various Workshops.Chaired more than 110 conferences/ workshops & seminars and published around 90 papers. Life member of various national and International Associations.
Chief Scientific OfficerGradalis, Inc. USA
Dr. Nemunaitis is the Chief Scientific Officer of Gradalis, Inc. He leads development of immunotherapeuticsproducts under development at Gradalis. One product, Vigil, is at late stage development for product registration in ovarian cancer. Gradalis is a biotechnology company that Dr. Nemunaitis is a co-founder of since 2003. Dr. Nemunaitisearned his medical degree at Case Western Reserve University in Cleveland, Ohio, followed by residency training at Boston City Hospital in Massachusetts. He also completed a fellowship in oncology/hematology at the University of Washington School of Medicine’s Fred Hutchinson Cancer Research Center in Seattle, Wash. He founded the Mary Crowley Cancer Research Translational Center and two biotech companies (Strike and Gradalis) before coming to Toledowhere he was Chief of UT’s Division of Hematology and Oncology, Medical Director of the Eleanor N. Dana Cancer Center at The University of Toledo and Director of UT’s Jacobson Center for Clinical and Translational Research. His specialties include general oncology, clinical trial development, genetic signal mapping and precision therapy. Likewise, his current research interests involve targeted immunotherapy, targeted molecular therapy and bioinformatics profiling. He is board-certified in internal medicine. Dr. Nemunaitis has published 475 peer reviewed manuscripts and book chapters, has overseen management of over 600 clinical trials involving several thousand cancer patients, has carried out 72 government regulatory (FDA, RAC, IND) presentations for biotechnology product development and has filled 25 patent application and received 11 issued targeted therapeutic patents.
Agostino Gemelli University Policlinic Italy
Gianluca Franceschini is 2nd level Professor of General Surgery at the University Department of Translational Medicine and Surgery of the Catholic University of the Sacred Heart since January 1, 2017. He is Head of the Simple Unit of Integrated Therapies in Breast Care, in the Department of "Women's, Child and Public Health Sciences" of the “Agostino Gemelli” IRCCS University Hospital Foundation in Rome since 1 July 2014. He is Professor for the Faculty of Medicine and Surgery “A. Gemelli " of the Catholic University of the Sacred Heart of Rome in the single-cycle degree course in Medicine and Surgery, in the Degree Course in Obstetrics, in the Degree Course in Audiprosthetic Techniques, in the Specialization School Courses in Medical Oncology, Surgery General and Plastic, Reconstructive and Aesthetic Surgery, in PhD Schools. Over the years he has gained particular expertise in the surgical treatment of breast tumors and in particular in the use of oncoplastic surgery techniques. He is the author of over 200 publications in national and international journals concerning breast pathology. He is Member of the Editorial Board of the following scientific journals: Translational Cancer Research (IF and Scopus); Italian Annals of Surgery (IF and Scopus); Minerva Chirurgica (IF and Scopus); European Review for Medical and Pharmacological Sciences (IF and Scopus); Surgical Oncology section Frontiers in Oncology (IF and Scopus); Future Oncology (IF and Scopus); European Journal of Breast Health; Annals of Breast Surgery; Surgery in Practice and Science; Clinical Radiology and Imaging Journal; Journal of Cancer Treatment and Research (JCTR); Journal of Cancer Research Forecast; Oncogen Journal; Annals of Surgical Education; International Journal of Transplantation & Plastic Surgery. He is Reviewer for the following scientific journals: The Lancet Oncology; European Journal of Surgical Oncology; The Breast; Breast Care; British Journal of Surgery; Surgical Oncology; Carbohydrate Polymers; Gynecology and Obstetrics Investigation; Italian Annals of Surgery; Breast Cancer Management; - Expert System; Journal of International Medical Research; International Journal of Computer Assisted Radiology and Surgery (verified on Publons). He is Guest Editor for the following scientific journals: Journal of Personalized Medicine; Translational Cancer Research; Surgical Oncology section Frontiers in Oncology. He is enrolled in "REPRISE" (Register of Scientific Experts established at the MIUR) for the Basic Research section. He obtained the Honorary Citizenship of the Country of Allumiere (RM) for his social and scientific commitment in the fight against breast cancer in October 2015. He is a Founding Member of the non-profit organization “Susan G. Komen Italia”, of which he was a member of the Board of Directors from February 2005 to January 2013 and Secretary from February 2005 to January 2009. He was selected by the Umberto Veronesi Foundation, as a breast surgeon, to be part of the medical-health team specialized in the diagnosis and treatment of breast cancer and involved in the “Breast Cancer Task Force” project for the fight against breast cancer. He is evaluator for "McMaster Online Rating of Evidence (MORE) System" (Health Information Research Unit, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario). He is a certified member of the Italian College of Breast Surgeons and a member of the Italian National Association of Breast Surgeons (ANISC). He was appointed as a Scientific Director of the Senology Department of the UniverSalus University Consortium founded by the Lumsa University and the Humanitas University Consortium on 1 October 2020.